- Home
- ICCM vs TRT Comparison
ICCM vs TRT Comparison
Compare ICCM & TRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCM
- TRT
- Stock Information
- Founded
- ICCM 2006
- TRT 1958
- Country
- ICCM Israel
- TRT United States
- Employees
- ICCM N/A
- TRT N/A
- Industry
- ICCM
- TRT Industrial Machinery/Components
- Sector
- ICCM
- TRT Technology
- Exchange
- ICCM Nasdaq
- TRT Nasdaq
- Market Cap
- ICCM 33.8M
- TRT 30.5M
- IPO Year
- ICCM N/A
- TRT N/A
- Fundamental
- Price
- ICCM $0.62
- TRT $7.10
- Analyst Decision
- ICCM Strong Buy
- TRT
- Analyst Count
- ICCM 2
- TRT 0
- Target Price
- ICCM $2.70
- TRT N/A
- AVG Volume (30 Days)
- ICCM 1.1M
- TRT 10.7K
- Earning Date
- ICCM 11-26-2024
- TRT 11-12-2024
- Dividend Yield
- ICCM N/A
- TRT N/A
- EPS Growth
- ICCM N/A
- TRT N/A
- EPS
- ICCM N/A
- TRT 0.24
- Revenue
- ICCM $3,336,000.00
- TRT $42,312,000.00
- Revenue This Year
- ICCM $18.61
- TRT N/A
- Revenue Next Year
- ICCM $54.91
- TRT N/A
- P/E Ratio
- ICCM N/A
- TRT $29.92
- Revenue Growth
- ICCM 3.60
- TRT 2.10
- 52 Week Low
- ICCM $0.48
- TRT $4.64
- 52 Week High
- ICCM $1.57
- TRT $7.88
- Technical
- Relative Strength Index (RSI)
- ICCM 44.56
- TRT 58.32
- Support Level
- ICCM $0.56
- TRT $6.54
- Resistance Level
- ICCM $0.63
- TRT $7.19
- Average True Range (ATR)
- ICCM 0.07
- TRT 0.38
- MACD
- ICCM -0.01
- TRT 0.02
- Stochastic Oscillator
- ICCM 20.61
- TRT 77.59
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.